Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
18.46M | 30.59M | 26.23M | 47.33M | 38.41M | 58.08M | Gross Profit |
-188.00K | -436.00K | -194.00K | 98.00K | 632.00K | 5.50M | EBIT |
-3.74M | -6.01M | -11.12M | -13.59M | -5.70M | -1.69M | EBITDA |
-2.92M | -3.13M | -6.78M | -12.96M | -4.83M | -1.02M | Net Income Common Stockholders |
-4.89M | -5.97M | -9.79M | -2.69M | -5.22M | -1.27M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
12.39M | 817.00K | 4.39M | 7.17M | 4.30M | 1.60M | Total Assets |
26.82M | 11.23M | 19.66M | 32.63M | 20.67M | 18.55M | Total Debt |
128.00K | 247.00K | 2.11M | 2.40M | 387.00K | 691.00K | Net Debt |
-12.27M | -570.00K | -2.28M | -4.78M | -3.91M | -912.00K | Total Liabilities |
4.35M | 4.98M | 7.36M | 10.87M | 8.19M | 7.14M | Stockholders Equity |
22.47M | 6.25M | 12.30M | 21.77M | 12.54M | 11.47M |
Cash Flow | Free Cash Flow | ||||
-1.74M | -2.09M | -3.19M | -10.33M | -1.68M | -6.43M | Operating Cash Flow |
-1.71M | -2.01M | -3.19M | -8.84M | 326.00K | -4.31M | Investing Cash Flow |
584.02K | -1.54M | 552.00K | -5.47M | -3.47M | -2.16M | Financing Cash Flow |
876.00K | 0.00 | -40.00K | 17.11M | 5.82M | 4.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $31.66B | 9.79 | 9.14% | ― | -2.60% | 16.71% | |
63 Neutral | $2.31B | 8.06 | 8.74% | ― | -0.29% | -12.84% | |
59 Neutral | $27.83B | 1.88 | -18.16% | 4.00% | 2.13% | -44.45% | |
53 Neutral | $123.91M | ― | -24.55% | ― | ― | ― | |
48 Neutral | $379.73M | ― | -10.12% | ― | -0.38% | -61.79% | |
41 Neutral | $26.23M | ― | -4.47% | ― | 0.22% | 49.14% | |
36 Underperform | $3.43M | ― | -74.75% | ― | -37.93% | -23.27% |
ZW Data Action Technologies Inc. announced the resignation of Kevin Choi as an independent director, with no disagreement cited between him and the company. Justin Tam, with extensive experience in business development and healthcare technology, has been appointed as the new independent director, meeting qualifications according to Nasdaq Marketplace Rules.